Remington

Adeboye Adejare’s research group is interested in the areas of design and syntheses of small organic molecules to probe neurodegeneration, especially Alzheimer’s disease, and for treatment of cancer. They are also interested in in vitro models of drug absorption and ability to cross blood brain barrier; drug targeting; pharmaceutical profiling; and chemistry of fluoroaromatic compounds. The research is funded by the National Institutes of Health, the Office of Naval Research, and several pharmaceutical companies. These efforts have resulted in over 50 publications, 5 patents, and over 100 presentations at meetings, including invited presentations at national and international conferences. He also serves on several national panels, including those by NIH, NSF, and Alzheimer’s Association. Dr. Adejare is the editor of Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease which is also published by Elsevier.

Section 1: Introduction Section 2: Natural Products Section 3: Pharmaceutical Chemistry Section 4: Pharmacokinetics/Pharmacodynamics Section 5: Pharmaceutics Section 6: Biopharmaceutics Section 7: Pharmaceutical Materials and Devices/Industrial Pharmacy Section 8: Translational Research Section 9: Pharmacy Practice Section 10: Pharmaceutical Outcomes and Policy